Corcept Therapeutics Incorporated (CORT) — Net Asset Quality Index
Corcept Therapeutics Incorporated (CORT) has a Net Asset Quality Index of 78.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $814.88 Million minus total liabilities of $176.89 Million yields net assets of $637.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Corcept Therapeutics Incorporated asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Corcept Therapeutics Incorporated Net Asset Quality Index Over Time (2000–2025)
This chart shows how Corcept Therapeutics Incorporated's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of March 2026, the index stands at 78.3%, representing net assets of $637.99 Million against total assets of $814.88 Million USD. See working capital position of Corcept Therapeutics Incorporated to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Corcept Therapeutics Incorporated (2000–2025)
The table below presents the year-by-year Net Asset Quality Index for Corcept Therapeutics Incorporated from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CORT company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 77.4% | $647.80 Million | $836.65 Million | $188.85 Million | ▼ -3.4 pp |
| 2024 | 80.9% | $679.59 Million | $840.55 Million | $160.96 Million | ▼ -0.7 pp |
| 2023 | 81.5% | $506.70 Million | $621.52 Million | $114.81 Million | ▼ -4.5 pp |
| 2022 | 86.0% | $501.84 Million | $583.43 Million | $81.59 Million | ▼ -2.7 pp |
| 2021 | 88.7% | $375.81 Million | $423.76 Million | $47.95 Million | ▼ -2.9 pp |
| 2020 | 91.5% | $523.34 Million | $571.73 Million | $48.39 Million | ▲ +1.5 pp |
| 2019 | 90.0% | $371.18 Million | $412.31 Million | $41.13 Million | ▲ +1.5 pp |
| 2018 | 88.5% | $275.88 Million | $311.69 Million | $35.81 Million | ▲ +1.9 pp |
| 2017 | 86.6% | $190.97 Million | $220.54 Million | $29.57 Million | ▲ +26.4 pp |
| 2016 | 60.2% | $41.38 Million | $68.75 Million | $27.37 Million | ▲ +24.6 pp |
| 2015 | 35.6% | $18.50 Million | $51.94 Million | $33.44 Million | ▲ +45.4 pp |
| 2014 | -9.8% | $-3.39 Million | $34.63 Million | $38.02 Million | ▼ -43.1 pp |
| 2013 | 33.3% | $21.02 Million | $63.08 Million | $42.06 Million | ▼ -29.0 pp |
| 2012 | 62.3% | $61.78 Million | $99.17 Million | $37.39 Million | ▼ -25.1 pp |
| 2011 | 87.4% | $34.81 Million | $39.83 Million | $5.03 Million | ▲ +2.8 pp |
| 2010 | 84.6% | $21.24 Million | $25.10 Million | $3.86 Million | ▼ -5.5 pp |
| 2009 | 90.1% | $22.09 Million | $24.51 Million | $2.42 Million | ▲ +4.6 pp |
| 2008 | 85.5% | $16.91 Million | $19.77 Million | $2.87 Million | ▲ +2.5 pp |
| 2007 | 83.0% | $14.73 Million | $17.74 Million | $3.01 Million | ▲ +18.8 pp |
| 2006 | 64.2% | $6.36 Million | $9.90 Million | $3.54 Million | ▼ -24.0 pp |
| 2005 | 88.2% | $26.59 Million | $30.16 Million | $3.56 Million | ▼ -8.0 pp |
| 2004 | 96.2% | $45.95 Million | $47.77 Million | $1.82 Million | ▲ +9.2 pp |
| 2003 | 86.9% | $10.24 Million | $11.78 Million | $1.54 Million | ▲ +187.6 pp |
| 2002 | -100.7% | $-21.94 Million | $21.80 Million | $43.73 Million | ▼ -192.9 pp |
| 2001 | 92.2% | $22.38 Million | $24.26 Million | $1.88 Million | ▲ +111.0 pp |
| 2000 | -18.7% | $-196.00K | $1.05 Million | $1.24 Million | — |